02 JAN 2009 05:50 ERLYTX ACCRUAL REPORT - OPEN and recently closed STUDIES
REGS. REGS. REGS. REGS. REGS.
R LAST LAST LAST LAST LAST # of # of
E ACCR. TOTAL 12 6 3 30 7 ACT. CURR
STUDY G ARM GOAL REGS. Month Month Month DAYS DAYS INSTs IRBs
-------------------------------------- - --------------------------------- ----- ----- ----- ----- ----- ----- ----- ----- -----
S0528-Adv.Solid Tumors, Lapat.+Ever. 1 2 Lev 1,Lapat.750 mg,Ever. 2.5mg 48 7 0 0 0 0 0 9 8
4 Lev 2,Lapat.1000mg,Ever. 2.5mg 3 0 0 0 0 0
6 Lev 3,Lapat.1250mg,Ever. 2.5mg 3 0 0 0 0 0
7 Lev 4,Lapat.1250mg,Ever. 5mg 6 0 0 0 0 0
8 Levi5b,Lapat.1250mg,Ever. 10mg 2 2 0 0 0 0
9 Lev 5a,Lapat.1500mg,Ever. 5mg 5 5 0 0 0 0
11 Everolimus, then Lapat.+Ever. 16 16 16 14 0 0
12 Lapatinib, then Lapat.+Ever. 17 17 17 15 0 0
----- ----- ----- ----- ----- -----
59 40 33 29 0 0
* ***** ----- ***** *****
s 59
8 rows selected.
02 JAN 2009 05:50 ERLYTX Open Studies with No Registrations
Study Registration/Phase Open Date
---------------------------------------- ----------------------------------- ---------
S0711 Liver dysfunction PK,Dasatinib 1 Registration 15-Oct-08
1 row selected.
no rows selected
SWOG StatCtr Home Page
1 row selected.